Invitae Corp NVTA:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/14/21 EDT
31.60quote price arrow up+0.07 (+0.22%)
Volume
51,445
Close
31.53UNCH (UNCH)
Volume
2,879,209
52 week range
15.45 - 61.59

...

Loading . . .
  • Open31.34
  • Day High32.08
  • Day Low31.16
  • Prev Close31.22
  • 52 Week High61.59
  • 52 Week High Date12/14/20
  • 52 Week Low15.45
  • 52 Week Low Date06/15/20

Key Stats

  • Market Cap6.611B
  • Shares Out209.68M
  • 10 Day Average Volume2.92M
  • Dividend-
  • Dividend Yield-
  • Beta1.88
  • YTD % Change-24.59

KEY STATS

  • Open31.34
  • Day High32.08
  • Day Low31.16
  • Prev Close31.22
  • 52 Week High61.59
  • 52 Week High Date12/14/20
  • 52 Week Low15.45
  • 52 Week Low Date06/15/20
  • Market Cap6.611B
  • Shares Out209.68M
  • 10 Day Average Volume2.92M
  • Dividend-
  • Dividend Yield-
  • Beta1.88
  • YTD % Change-24.59

RATIOS/PROFITABILITY

  • EPS (TTM)-3.93
  • P/E (TTM)-8.02
  • Fwd P/E (NTM)-12.69
  • EBITDA (MRQ)-594.584M
  • ROE (MRQ)-45.38%
  • Revenue (MRQ)318.97M
  • Gross Margin (MRQ)26.84%
  • Net Margin (MRQ)-192.22%
  • Debt To Equity (MRQ)19.17%

EVENTS

  • Earnings Date08/02/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. As of December 31, 2016, the Company's products consisted of assays totaling over 1,100 genes that could be used for multiple indications, including hereditary cancer...
Eric Aguiar M.D.
Non-Executive Chairman
Sean George Ph.D.
President
Kenneth Knight
Chief Operating Officer
Shelly Guyer
Chief Financial Officer
Robert Werner
Chief Accounting Officer
Thomas Brida J.D.
General Counsel
Address
1400 16th St
San Francisco, CA
94103-5110
United States

Top Peers

SYMBOLLASTCHG%CHG
HALO
Halozyme Therapeutics Inc
43.36UNCHUNCH
RARE
Ultragenyx Pharmaceutical Inc
102.88UNCHUNCH
APLS
Apellis Pharmaceuticals Inc
64.90+2.78+4.48%
PACB
Pacific Biosciences of California Inc
29.51UNCHUNCH
TWST
Twist Bioscience Corp
112.77UNCHUNCH